Plasma Cell Neoplasm: Clinical Trials

4 trials for Plasma Cell Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Withdrawn 1

Follow Plasma Cell Neoplasm: new trials by email Literature Review of Plasma Cell Neoplasm trials Research Report on Plasma Cell Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Not applicableCompletedRoswell Park Cancer Institute1742006-06-292021-04-22
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
epoetin alfa - Anemia, Multiple Myeloma
Not applicableCompletedThe Cleveland Clinic312003-09-012018-02-22
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
chemoprotection, complementary or alternative medicine procedure, management of therapy complications - Multiple Myeloma, Plasma Cell Neoplasm
Not applicableCompletedFred Hutchinson Cancer Center412003-07-012011-09-01

Narrower conditions

Neoplasms, Plasma Cell (4)  ·  Multiple Myeloma (3)  ·  Burkitt Lymphoma (2)  ·  Congenital Abnormalities (2)  ·  Hodgkin Disease (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Large-Cell, Immunoblastic (2)  ·  Lymphoma, Mantle-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell, Cutaneous (2)  ·  Neuroblastoma (2)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Blood Protein Disorders (3)  ·  Cardiovascular Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Paraproteinemias (3)  ·  Vascular Diseases (3)  ·  Chronic Disease (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)

Interventions

Busulfan (1)  ·  Carboplatin (1)  ·  Carmustine (1)  ·  Cyclophosphamide (1)  ·  Epoetin Alfa (1)  ·  Etoposide (1)  ·  Melphalan (1)  ·  Therapeutics (1)  ·  Thiotepa (1)  ·  Whole-Body Irradiation (1)

Sponsors

Roswell Park Cancer Institute (2)  ·  Fred Hutchinson Cancer Center (1)  ·  The Cleveland Clinic (1)

Countries

United States (3)

Top investigators

Philip McCarthy (2)  ·  Ronald M. Sobecks, MD (1)  ·  William I. Bensinger, MD (1)

NIH funding

P30CA016056 (1), P30CA043703 (1)